全球炎症性腸病治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342882

全球炎症性腸病治療市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Inflammatory Bowel Disease Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2個工作天內

價格

全球炎症性腸病治療市場的需求預計將從 2022 年的 270 億美元增至 2030 年的近 501.8 億美元,2023-2030 年研究期間年複合成長率為 7.13%。

炎症性腸病 (IBD) 是指腸道或消化道發炎的幾種慢性疾病。消化道和腸道均受到兩種類型 IBD 的影響。一些治療方法可以幫助控制這種慢性疾病。 IBD 治療的目標是減少炎症。在最好的情況下,這可能會導致症狀緩解、長期緩解並降低併發症的風險。手術和藥物治療用於治療 IBD。

市場動態:

由於生活方式、社會和環境變化等多種因素,潰瘍性結腸炎和克隆氏症的患病率在全球範圍內不斷上升,最終將推動炎症性腸病治療市場的發展。此外,已開發國家更高的疾病診斷率和報銷政策促進了市場的擴張,早期疾病診斷變得更加重要。此外,隨著人們意識到生物製劑、皮質類固醇等藥物的優勢,炎症性腸病的治療正在蓬勃發展。同樣,隨著越來越多的人受到 IBD 影響,用於治療炎症性腸病的有前途的管道藥物的日益普及將推動市場成長,從而增加對有效治療替代方案的需求。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具還對全球炎症性腸病治療市場的各個細分市場進行了包容性評估。炎症性腸病治療行業的成長和趨勢為本研究提供了整體方法。

區域分析:

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲炎症性腸病治療市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。炎症性腸病治療市場的主要參與者包括艾伯維公司、百健公司、強生服務公司、安進公司、UCB SA、諾華公司、武田製藥有限公司、默克公司、輝瑞公司、莉莉。本節包含競爭格局的整體視圖,包括各種戰略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:炎症性腸病治療 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按藥品類別分類的市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章:COVID-19 爆發的影響分析

第 6 章:全球炎症性腸病治療市場分析:按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 克隆氏症
  • 潰瘍性結腸炎

第 7 章:全球炎症性腸病治療市場分析:按藥物類別

  • 按藥物類別概述
  • 歷史和預測數據
  • 按藥物類別分析
  • 氨基水楊酸鹽
  • 皮質類固醇
  • 腫瘤壞死因子抑製劑
  • 白細胞介素抑製劑
  • 抗整合素
  • JAK抑製劑
  • 其他

第 8 章:全球炎症性腸病治療市場分析:按給藥途徑

  • 按給藥途徑概述
  • 歷史和預測數據
  • 按給藥途徑分析
  • 口服
  • 可注射

第 9 章:全球炎症性腸病治療市場分析:按配銷通路

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥房
  • 網上藥房

第 10 章:全球炎症性腸病治療市場分析:按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 11 章:炎症性腸病治療公司的競爭格局

  • 炎症性腸病治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 12 章:公司簡介

  • 頂級公司股票分析
  • 市場集中度
  • AbbVie Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biogen
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Johnson & Johnson Services Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Amgen Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • UCB SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Novartis AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Takeda Pharmaceutical Company Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merck & Co. Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Pfizer Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lilly
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中,財務詳細資訊和近期發展視情況而定,或者如果是私營公司,則可能不包括在內

Product Code: VMR11219393

The global demand for Inflammatory Bowel Disease Treatment Market is presumed to reach the market size of nearly USD 50.18 BN by 2030 from USD 27 BN in 2022 with a CAGR of 7.13% under the study period 2023 - 2030.

Inflammatory bowel disease (IBD) refers to several chronic disorders where the gut or digestive tract is inflamed. The digestive and intestinal tract is affected by both types of IBD. Some treatments can help with the management of this chronic illness. The goal of IBD treatment is to reduce inflammation. In the best-case situation, this might lead to symptom relief, long-term remission, and a decreased risk of complications. Surgery and drug therapy are used to treat IBD.

MARKET DYNAMICS:

The prevalence of ulcerative colitis and Crohn's disease is rising globally due to various factors, including lifestyle, societal and environmental changes, that will eventually fuel the market for inflammatory bowel disease treatment. In addition, a greater disease diagnosis rate and reimbursement policies in developed nations boost the market's expansion as early disease diagnosis becomes more important. Furthermore, inflammatory bowel disease treatment is surging as people become aware of the advantages of medications like biologics, corticosteroids, and others. Again, the increasing prevalence of promising pipeline medicines for inflammatory Bowel Disease treatment will propel market growth as more individuals become affected by IBD, increasing the demand for effective treatment alternatives.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of inflammatory bowel disease treatment. The growth and trends of inflammatory bowel disease treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the inflammatory bowel disease treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Crohn'S Disease
  • Ulcerative Colitis

By Drug Class

  • Aminosalicylates
  • Corticosteroids
  • TNF Inhibitors
  • IL Inhibitors
  • Anti-Integrin
  • JAK Inhibitors
  • Others

By Route Of Administration

  • Oral
  • Injectable

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Inflammatory Bowel Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen, Johnson & Johnson Services Inc., Amgen Inc., UCB S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Merck & Co. Inc., Pfizer Inc., Lilly. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INFLAMMATORY BOWEL DISEASE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Drug Class
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Crohn's Disease Historic and Forecast Sales by Regions
  • 6.5 Ulcerative Colitis Historic and Forecast Sales by Regions

7 . GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET ANALYSIS BY DRUG CLASS

  • 7.1 Overview by Drug Class
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Drug Class
  • 7.4 Aminosalicylates Historic and Forecast Sales by Regions
  • 7.5 Corticosteroids Historic and Forecast Sales by Regions
  • 7.6 TNF inhibitors Historic and Forecast Sales by Regions
  • 7.7 IL inhibitors Historic and Forecast Sales by Regions
  • 7.8 Anti-integrin Historic and Forecast Sales by Regions
  • 7.9 JAK inhibitors Historic and Forecast Sales by Regions
  • 7.10. Others Historic and Forecast Sales by Regions

8 . GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 8.1 Overview by Route Of Administration
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Route Of Administration
  • 8.4 Oral Historic and Forecast Sales by Regions
  • 8.5 Injectable Historic and Forecast Sales by Regions

9 . GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 9.1 Overview by Distribution Channel
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Distribution Channel
  • 9.4 Hospital Pharmacy Historic and Forecast Sales by Regions
  • 9.5 Retail Pharmacy Historic and Forecast Sales by Regions
  • 9.6 Online Pharmacy Historic and Forecast Sales by Regions

10 . GLOBAL INFLAMMATORY BOWEL DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE INFLAMMATORY BOWEL DISEASE TREATMENT COMPANIES

  • 11.1. Inflammatory Bowel Disease Treatment Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF INFLAMMATORY BOWEL DISEASE TREATMENT INDUSTRY

  • 12.1. Top Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. AbbVie Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Biogen
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Johnson & Johnson Services Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Amgen Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. UCB S.A.
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Novartis AG
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Takeda Pharmaceutical Company Limited
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Merck & Co. Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Pfizer Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Lilly
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • Analysis Market by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Corticosteroids Market Sales by Geography (USD MN)
  • TNF inhibitors Market Sales by Geography (USD MN)
  • IL inhibitors Market Sales by Geography (USD MN)
  • Anti-integrin Market Sales by Geography (USD MN)
  • JAK inhibitors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Global Inflammatory Bowel Disease Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Inflammatory Bowel Disease Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Inflammatory Bowel Disease Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Crohn's Disease Market Sales by Geography (USD MN)
  • Ulcerative Colitis Market Sales by Geography (USD MN)
  • Global Market Analysis by Drug Class (USD MN)
  • Aminosalicylates Market Sales by Geography (USD MN)
  • Corticosteroids Market Sales by Geography (USD MN)
  • TNF inhibitors Market Sales by Geography (USD MN)
  • IL inhibitors Market Sales by Geography (USD MN)
  • Anti-integrin Market Sales by Geography (USD MN)
  • JAK inhibitors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route Of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Injectable Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacy Market Sales by Geography (USD MN)
  • Retail Pharmacy Market Sales by Geography (USD MN)
  • Online Pharmacy Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.